Yvonne GreenstreetFiled
- ALNYALNYLAM PHARMACEUTICALS, INC.Chief Executive Officerfiled Sep 22, 2026
Monthly open-market value · 24 months Filed
- Bought (open market)
- Sold (open market)
Unusual activity Estimated
- 50Insider overlapPublic Jun 22, 2025 · traded May 12, 2025
Rep. Jefferson Shreve sold ALNY 18 days before its CEO sold $7.7M
Details
- Politician
- Jefferson Shreve
- Ticker
- ALNY
- Asset
- Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)
- Tx type
- sell
- Traded
- May 12, 2025
- Filed
- Jun 22, 2025
- Amount low
- $15,001
- Amount high
- $50,000
- Range midpoint (estimate)
- $32,501
- Disclosed range
- $15,001 - $50,000
- Reporting lag days
- 41
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"yvonne-greenstreet","name":"Yvonne Greenstreet","title":"Chief Executive Officer","short_title":"CEO"},"company":"ALNYLAM PHARMACEUTICALS, INC.","ticker":"ALNY","tx_kind":"open_market_sale","tx_date":"2025-05-30","shares":25469,"price":304,"value":7742576,"is_10b5_1":true,"filing_date":"2025-06-03"}
- Days between
- -18
- Opposite side
- No
- Public from
- Jun 22, 2025
- Method version
- 2026-11-03
- 28Exec salePublic Jun 3, 2025 · traded May 30, 2025
ALNY CEO Yvonne Greenstreet sold $7.7M (10b5-1 plan)
Details
- Insider
- Yvonne Greenstreet
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Ticker
- ALNY
- Tx kind
- open_market_sale
- Traded
- May 30, 2025
- Shares
- 25,469
- Price
- $304
- Value
- $7.7M
- Is 10b5 1
- Yes
- Filed
- Jun 3, 2025
- Public from
- Jun 3, 2025
- Method version
- 2026-11-03
- 26Exec salePublic Jun 3, 2025 · traded Jun 2, 2025
ALNY CEO Yvonne Greenstreet sold $5.9M (10b5-1 plan)
Details
- Insider
- Yvonne Greenstreet
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Ticker
- ALNY
- Tx kind
- open_market_sale
- Traded
- Jun 2, 2025
- Shares
- 19,297
- Price
- $306
- Value
- $5.9M
- Is 10b5 1
- Yes
- Filed
- Jun 3, 2025
- Public from
- Jun 3, 2025
- Method version
- 2026-11-03
Transactions
Independent third-party platform; not affiliated with or endorsed by any member of Congress. Data sourced from publicly available filings and records. Portfolio, holdings, returns, and allocations are estimates and may differ from actual values. Informational and educational only; not investment advice. Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4; the whale score is a model ranking of that filed activity.